On August 22, 2025, Nutex Health Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of Texas on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”).

On August 21, 2025, Snap, Inc. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired Snap securities between April 29, 2025, to August 5, 2025, inclusive (the “Class Period”).

On August 20, 2025, PubMatic, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired PubMatic securities between February 27, 2025 and August 11, 2025, inclusive (the “Class Period”).

On August 15, 2025, Unicycive Therapeutics Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Unicycive securities between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class Period”).

On August 14, 2025, Charter Communications, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Charter securities, purchased call options on Charter common stock, or sold put options on Charter common stock, between July 26, 2024, and July 24, 2025, inclusive (the “Class Period”).

On August 12, 2025, KinderCare Learning Companies, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Oregon on behalf of all purchasers of KinderCare common stock in or traceable to the Company’s October 2024 initial public offering (the “IPO”).

On August 11, 2025, SelectQuote, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired SelectQuote securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”).

On August 8, 2025, CTO Realty Growth, Inc. was sued for violations of the federal securities laws in the United States District Court for the Middle District of Florida on behalf of investors who purchased or otherwise acquired CTO securities between February 18, 2021 and June 24, 2025, both dates inclusive (the “Class Period”).

On August 5, 2025, Altimmune, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Maryland on behalf of investors who purchased or otherwise acquired Altimmune securities between August 10, 2023 and June 25, 2025, inclusive (the “Class Period”).

On August 4, 2025, Tesla, Inc. was sued for violations of the federal securities laws in the United States District Court for the Western District of Texas on behalf of investors who purchased or otherwise acquired Tesla securities between
April 19, 2023 and June 22, 2025, both dates inclusive (the “Class Period”).

On August 1, 2025, Novo Nordisk A/S was sued for violations of the federal securities laws in the United States District Court for the Central District of New Jersey on behalf of investors who purchased or otherwise acquired Novo securities between May 7, 2025, to July 28, 2025, inclusive (the “Class Period”).

On August 1, 2025, Lineage, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Michigan on behalf of all purchasers of Lineage common stock in or traceable to the registration statement used in connection with the Company’s July 2024 initial public offering (the “IPO”).

On July 28, 2025, Lockheed Martin Corporation was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired Lockheed Martin securities between January 23, 2024 and July 21, 2025, inclusive (the “Class Period”).

On July 28, 2025, Sable Offshore Corp. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired publicly traded Sable Offshore securities between May 19, 2025 and June 3, 2025, inclusive (the “Class Period”), and/or pursuant and/or traceable to the Company’s May 21, 2025 secondary public offering (the “SPO”).

On July 25, 2025, Flywire Corporation was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased or otherwise acquired Flywire securities between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class Period”).

On July 24, 2025, Replimune Group, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of Massachusetts on behalf of investors who purchased or otherwise
acquired publicly traded Replimune securities between November 22, 2024 and July 21, 2025, inclusive (the “Class Period”).

On July 24, 2025, Fiserv, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Fiserv common stock between July 24, 2024 and July 22, 2025, inclusive (the “Class Period”).

On July 23, 2025, Luminar Technologies, Inc. was sued for violations of the federal securities laws in the United States District Court for the Middle District of Florida on behalf of investors who purchased or otherwise acquired Luminar securities between March 20, 2025, and May 14, 2025, inclusive (the “Class Period”).

On July 22, 2025, RxSight, Inc. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired RxSight securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”).

On July 21, 2025, Alto Neuroscience, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired: (a) Alto common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about February 2, 2024 (the “IPO” or “Offering”); and/or (b) Alto
securities between February 2, 2024 and October 22, 2024, both dates inclusive (the “Class Period”).